• Users Online: 27
  • Print this page
  • Email this page
RESEARCH ARTICLE
Year : 2015  |  Volume : 14  |  Issue : 1  |  Page : 14-17

The effectiveness of vaginal lisuride in the treatment of hyperprolactinemia


Correspondence Address:
Hind Abdul khaliq Nassir
Lecturer, Department Of Gynecology & obstetrics, Al Mustansiriya Medical Collage

Login to access the Email id

Source of Support: None, Conflict of Interest: None


Get Permissions

Get Permissions

Background: hyperprolactinemia is a disorder which may be represented clinically by one or more of the following: galactorrhea, infertility, oligmenorrhea, amenorrhea, luteal phase defect and hirsutisim, lisuride drug was recently used vaginaly in the treatment of hyperprolactinemia to decrease the side effects by it's use orally. Patients & Methods: An interventional study conducted over a period of one year from October 2011 to October 2012, in Al-Yarmok Teaching Hospital, 50 patients presented with one or more of the following symptoms, abnormal menstrual cycle (amenorrhea, oligmenorrhea), infertility (unovulatory), galactorrhea. All the 50 patients with elevated prolactin level were received lisuride (dopergin) 0.2 mg vaginally at bed time and continued for 12 weeks, serum prolactin was measured at 8,12 weeks with monitoring of ovulation by serial U/S. Results: The study include fifty patients with mean age was 27.2 years ± SD7.01, and there mean weight was 62.1kg ± SD9.08 All 50 patients had elevated serum prolactin level with mean 66.1ng/ml ± SD 15.5, at the end of the treatment the range of serum prolactin level between 6-17ng/ml ± SD2.9, which was significantly lower than pre treatment level P =0.0001 At the end of the treatment 86% achieved regular cycle, Ovulation occur in significant number of patients p value < 0.01, (37.5%) of them get pregnancy. less side effect compared to oral lisurid. Conclusion: Vaginal lisurid is an effective drug used for the treatment of hyperprolactinemia to avoid the discontinuation of the drug because of it's side effect, when given orally.


[PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed60    
    Printed8    
    Emailed0    
    PDF Downloaded10    
    Comments [Add]    

Recommend this journal